These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15943767)

  • 1. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
    Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
    Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro candidacidal activity of a synthetic killer decapeptide (KP) against Candida albicans cells adhered to resin acrylic discs.
    Manfredi M; Merigo E; Salati A; Conti S; Savi A; Polonelli L; Bonanini M; Vescovi P
    J Oral Pathol Med; 2007 Sep; 36(8):468-71. PubMed ID: 17686004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies.
    Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
    J Antibiot (Tokyo); 2006 Feb; 59(2):73-9. PubMed ID: 16629406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From yeast killer toxins to antibiobodies and beyond.
    Magliani W; Conti S; Travassos LR; Polonelli L
    FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide.
    Fiori PL; Mattana A; Dessì D; Conti S; Magliani W; Polonelli L
    J Antimicrob Chemother; 2006 May; 57(5):891-8. PubMed ID: 16507561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
    Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
    Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide.
    Kabir ME; Karim N; Krishnaswamy S; Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
    Appl Microbiol Biotechnol; 2011 Dec; 92(6):1151-60. PubMed ID: 21691785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
    Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
    FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfaces of the yeast killer phenomenon.
    Polonelli L; Conti S; Gerloni M; Magliani W; Chezzi C; Morace G
    Crit Rev Microbiol; 1991; 18(1):47-87. PubMed ID: 1854433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies.
    Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
    J Biochem; 2010 May; 147(5):723-33. PubMed ID: 20097900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.
    Polonelli L; Magliani W; Conti S; Bracci L; Lozzi L; Neri P; Adriani D; De Bernardis F; Cassone A
    Infect Immun; 2003 Nov; 71(11):6205-12. PubMed ID: 14573638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies.
    Magliani W; Conti S; Giovati L; Maffei DL; Polonelli L
    Front Biosci; 2008 May; 13():6920-37. PubMed ID: 18508705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
    Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
    J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci.
    Conti S; Magliani W; Arseni S; Dieci E; Frazzi R; Salati A; Varaldo PE; Polonelli L
    Mol Med; 2000 Jul; 6(7):613-9. PubMed ID: 10997342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of killer yeasts in isolates of clinical origin.
    Robledo-Leal E; Villarreal-Treviño L; González GM
    Trop Biomed; 2012 Jun; 29(2):297-300. PubMed ID: 22735852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the in vitro antimycotic activity of a novel killer protein from Williopsis saturnus DBVPG 4561 against emerging pathogenic yeasts.
    Buzzini P; Corazzi L; Turchetti B; Buratta M; Martini A
    FEMS Microbiol Lett; 2004 Sep; 238(2):359-65. PubMed ID: 15358421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
    Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.